Is rituximab superior to cyclophosphamide for ANCA-associated vasculitis for induction of remission, and with a better safety profile?
Curr Rheumatol Rep
.
2010 Dec;12(6):395-8.
doi: 10.1007/s11926-010-0133-y.
Authors
Ignacio Garcia-Valladares
1
,
Luis R Espinoza
Affiliation
1
Section of Rheumatology, Department of Internal Medicine, Louisiana State University Health Sciences Center at New Orleans, New Orleans, LA 70112-2822, USA.
PMID:
20844995
DOI:
10.1007/s11926-010-0133-y
No abstract available
Publication types
Comment